GBp 126.5
(1.61%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -25.5 Million | -10.4 Million | 100.1 Million | 33.1 Million | -27 Million | -28.5 Million |
Net Income | -38.3 Million | -12.9 Million | 64.1 Million | -108.1 Million | -84.2 Million | -50.7 Million |
Depreciation & Amortization | 16.7 Million | 15.2 Million | 13.9 Million | 17.2 Million | 14.9 Million | 8.2 Million |
Deferred income taxes | -17.8 Million | - | -30.6 Million | 135.3 Million | 44.2 Million | 500 Thousand |
Stock-based compensation | 5.6 Million | 4.7 Million | 8.5 Million | 5.4 Million | 7.7 Million | 8.1 Million |
Change in working capital | 21.2 Million | 5.1 Million | 47.8 Million | -22.3 Million | -8.8 Million | -500 Thousand |
Other non-cash items | -12.9 Million | -22.5 Million | -3.6 Million | 5.6 Million | -800 Thousand | 5.9 Million |
Investing Cash Flow | 66.3 Million | 162 Million | 310.9 Million | 22.2 Million | -751.8 Million | -13.5 Million |
Investments in PPE | -12.2 Million | -13.9 Million | -9.4 Million | -10.3 Million | -17.2 Million | -13.3 Million |
Acquisitions | 1.1 Million | 5.1 Million | 3.9 Million | 1.9 Million | -13.9 Million | - |
Investment purchases | -18.4 Million | -6.4 Million | -235.6 Million | -332.8 Million | -797.2 Million | -1.1 Million |
Sales/Maturities of investments | 96.9 Million | 49.5 Million | 179.4 Million | 215.7 Million | 37.4 Million | 200 Thousand |
Other Investing Activities | -1.1 Million | 127.7 Million | 372.6 Million | 147.7 Million | 39.1 Million | 900 Thousand |
Financing Cash Flow | 3.7 Million | -201.7 Million | -291.2 Million | -116.2 Million | 612.4 Million | 285.6 Million |
Debt repayment | -11.5 Million | -187 Million | -491.9 Million | -525.2 Million | -222.8 Million | -3.8 Million |
Dividends payments | - | - | - | - | - | -500 Thousand |
Common Stock Repurchased | -1.8 Million | -8.7 Million | - | - | - | - |
Common Stock Issuance | - | 100 Thousand | 400 Thousand | 200 Thousand | 700 Thousand | 301.1 Million |
Other Financing Activities | 1.2 Million | -6.1 Million | 200.3 Million | 408.8 Million | 834.5 Million | -15 Million |
Accounts receivables | -13.5 Million | 8.8 Million | 46.4 Million | -35.3 Million | -9.1 Million | -8.1 Million |
Accounts payables | 34.7 Million | -3.7 Million | 1.4 Million | 13 Million | 700 Thousand | 6.1 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 34.7 Million | - | - | - | -400 Thousand | - |
Cash at beginning of period | 177.7 Million | 224 Million | 103.3 Million | 164.5 Million | 333 Million | 88.9 Million |
Cash at end of period | 221.4 Million | 177.7 Million | 224 Million | 103.3 Million | 164.5 Million | 333 Million |
Capital Expenditure | -12.2 Million | -13.9 Million | -9.4 Million | -10.3 Million | -17.2 Million | -13.3 Million |
Effect of forex changes on cash | -800 Thousand | 3.8 Million | 900 Thousand | -300 Thousand | -2.1 Million | 500 Thousand |
Net cash flow / Change in cash | 43.7 Million | -46.3 Million | 120.7 Million | -61.2 Million | -168.5 Million | 244.1 Million |
Free Cash Flow | -37.7 Million | -24.3 Million | 90.7 Million | 22.8 Million | -44.2 Million | -41.8 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.25 Million | -6.25 Million | -38.3 Million | -20.2 Million | -10.1 Million | -18.1 Million |
Depreciation & Amortization | 3.4 Million | 3.4 Million | 16.7 Million | 8.4 Million | -2 Million | 8.3 Million |
Deferred income taxes | - | - | -17.8 Million | -8.35 Million | - | -6.65 Million |
Stock-based compensation | 2.5 Million | 2.5 Million | 5.6 Million | 2.65 Million | 2.65 Million | 150 Thousand |
Change in working capital | 450 Thousand | 450 Thousand | 21.2 Million | 11.1 Million | -4.4 Million | 10.1 Million |
Other non-cash items | -26.3 Million | -26.3 Million | -12.9 Million | -8.1 Million | 6.6 Million | -4.8 Million |
Investing Cash Flow | 8.15 Million | 8.15 Million | 66.3 Million | 15.4 Million | 7.7 Million | 50.9 Million |
Investments in PPE | -1.1 Million | -1.1 Million | -12.2 Million | -5.4 Million | -150 Thousand | -6.8 Million |
Acquisitions | - | - | 1.1 Million | -7.85 Million | - | -25.7 Million |
Investment purchases | -1.7 Million | - | -18.4 Million | -2.9 Million | - | -15.5 Million |
Sales/Maturities of investments | 25.5 Million | - | 96.9 Million | 23.7 Million | - | 73.2 Million |
Other Investing Activities | 9.25 Million | 9.25 Million | -1.1 Million | 7.85 Million | 7.85 Million | 25.7 Million |
Financing Cash Flow | 3.35 Million | 3.35 Million | 3.7 Million | 17.1 Million | 8.55 Million | -13.4 Million |
Debt repayment | -17.1 Million | - | -11.5 Million | -20.1 Million | - | -8.6 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -4.09 Million | -4.09 Million | -1.8 Million | - | - | -1.8 Million |
Common Stock Issuance | 200 Thousand | - | - | - | - | - |
Other Financing Activities | 7.44 Million | 7.44 Million | 1.2 Million | 600 Thousand | 8.55 Million | 600 Thousand |
Accounts receivables | 450 Thousand | 450 Thousand | -13.5 Million | -8.8 Million | -4.4 Million | -4.7 Million |
Accounts payables | -30.4 Million | - | 34.7 Million | 19.9 Million | - | 14.8 Million |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 221.4 Million | - | 177.7 Million | 203.5 Million | - | 177.7 Million |
Cash at end of period | 192.1 Million | -14.65 Million | 221.4 Million | 221.4 Million | 8.95 Million | 203.5 Million |
Capital Expenditure | -1.1 Million | -1.1 Million | -12.2 Million | -5.4 Million | -150 Thousand | -6.8 Million |
Effect of forex changes on cash | 50 Thousand | 50 Thousand | -800 Thousand | -50 Thousand | -50 Thousand | -350 Thousand |
Net cash flow / Change in cash | -29.3 Million | -14.65 Million | 43.7 Million | 17.9 Million | 8.95 Million | 25.8 Million |
Free Cash Flow | -27.3 Million | -27.3 Million | -37.7 Million | -19.9 Million | -7.4 Million | -17.8 Million |
CROX
OFG
6495
BIOT
GTY
ANRO